+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Medical Affairs Outsourcing Market by Delivery Mode (Hybrid, Offsite, Onsite), Service Type (Medical Audit Compliance, Medical Communications, Medical Information), End User, Therapeutic Area - Global Forecast 2025-2030- Product Image
Medical Affairs Outsourcing Market by Delivery Mode (Hybrid, Offsite, Onsite), Service Type (Medical Audit Compliance, Medical Communications, Medical Information), End User, Therapeutic Area - Global Forecast 2025-2030- Product Image
Sale

Medical Affairs Outsourcing Market by Delivery Mode (Hybrid, Offsite, Onsite), Service Type (Medical Audit Compliance, Medical Communications, Medical Information), End User, Therapeutic Area - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 199 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 4896732
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The medical affairs outsourcing market is evolving rapidly as life sciences organizations intensify their focus on operational efficiency, compliance, and technological sophistication. Senior decision-makers face a dynamic landscape shaped by increasing regulatory scrutiny, complex global supply chains, and demands for real-world evidence-driven value demonstration.

Market Snapshot: Medical Affairs Outsourcing Market Growth and Dynamics

The Medical Affairs Outsourcing Market is poised for robust growth, expanding from USD 11.16 billion in 2024 to USD 12.84 billion in 2025, and is projected to achieve a CAGR of 14.70%, reaching USD 25.43 billion by 2030. Escalating pressures from regulatory bodies and payers, alongside technological modernization, are accelerating adoption rates. Organizations are increasingly leveraging specialized service partners to navigate multifaceted regulatory environments and deliver agile scientific communication, data dissemination, and patient-centric initiatives in a time-sensitive manner.

Scope & Segmentation: Comprehensive Coverage of Market Drivers

This report delivers in-depth coverage of all critical segments, service dimensions, and regional trends within the medical affairs outsourcing landscape.

  • Delivery Modes: Hybrid models integrating digital tools and onsite engagement, Offsite services for specialized tasks, Onsite solutions for clinical oversight and regulatory compliance.
  • Service Types: Medical audit compliance, medical communications (education, scientific publications, training), information management, medical strategy optimization, advanced medical writing (clinical trial, manuscript, regulatory), pharmacovigilance (case processing, risk management, signal detection).
  • End Users: Biotech companies, contract research organizations, medical device manufacturers, pharmaceutical companies.
  • Therapeutic Areas: Cardiovascular (including arrhythmia and heart failure), infectious disease (HIV-AIDS, hepatitis, respiratory infections), neurology (Alzheimer’s, epilepsy, Parkinson’s), oncology (hematological and lung cancers, breast cancer).
  • Regional Footprint: Americas (United States, Canada, Brazil, Argentina, Mexico), Europe (Germany, UK, France, Italy, Spain, Russia and more), Middle East & Africa (GCC, Sub-Saharan Africa, UAE, Saudi Arabia, South Africa), Asia Pacific (China, India, Japan, Australia, South Korea, Southeast Asia).
  • Technology Integration: Digital platforms for real-time data sharing, analytics and artificial intelligence for evidence generation, sophisticated compliance tracking, and enhanced data security solutions.
  • Leading Providers: IQVIA Holdings Inc., Syneos Health, ICON plc, Parexel, Medpace, Thermo Fisher Scientific, Envision Pharma Group, Real Chemistry, Synergus, TGaS Advisors.

Key Takeaways: Strategic Insights for Senior Decision-Makers

  • Outsourcing enables organizations to reallocate internal resources towards core innovation and research functions, increasing overall agility and effectiveness.
  • Evolving models emphasize hybrid delivery, combining digital collaboration with onsite expertise to meet both compliance needs and engagement quality.
  • Providers with strong regulatory compliance frameworks and integrated quality management systems are now preferred, reflecting heightened audit and documentation requirements.
  • Rising payer expectations for tailored, outcomes-based evidence are influencing the demand for advanced analytics and communication capabilities from medical affairs partners.
  • Service providers are adapting to diverse segmentation needs, offering bundled services customized to therapeutic focus, project scale, and end-user profile.
  • Strategic partnerships between global and niche firms are expanding capabilities, facilitating service innovation, and enhancing competitive positioning in new geographies.

Tariff Impact: Navigating New U.S. Policies

Recent U.S. tariffs on medical equipment and scientific services are prompting organizations to reevaluate supply chain strategies and operational cost models. Companies are responding by localizing key service functions, diversifying regional vendor networks, and adopting digital solutions that reduce reliance on cross-border transactions. This adaptation minimizes project delays and administrative burdens linked to fluctuating trade policies, helping maintain service quality amid uncertainty.

Methodology & Data Sources

The research integrates qualitative insights from senior executives and outsourcing specialists with a systematic review of peer-reviewed journals and regulatory publications. Analytical modeling triangulates quantitative and qualitative findings, ensuring credible, actionable intelligence for stakeholders.

Why This Report Matters

  • Enables informed decision-making by mapping current and emerging trends across services, regions, and technologies.
  • Guides strategies to address regulatory volatility, tariff impacts, and rapidly shifting stakeholder requirements.
  • Assists in identifying high-growth segments and selecting optimum delivery modes for specific business objectives.

Conclusion

Medical affairs outsourcing is experiencing notable transformation as digital innovation, compliance rigor, and segmentation complexity shape market strategies. Access this report to strengthen competitive positioning and craft resilient, future-ready operational models in a challenging regulatory and economic environment.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Expansion of real-world evidence generation services through specialized outsourced medical affairs partners to support regulatory submissions
5.2. Integration of patient engagement and advocacy program management within outsourced medical affairs to enhance patient centricity
5.3. Adoption of advanced AI-driven literature review and scientific writing services by medical affairs outsourcing providers for faster content production
5.4. Growing demand for multilingual medical communication and translation services in global medical affairs outsourcing to support emerging markets
5.5. Collaboration between outsourced medical affairs and health economics teams to deliver integrated value demonstration and pricing strategies
5.6. Utilization of digital health platforms and virtual advisory boards by outsourced medical affairs teams to drive remote expert engagement
5.7. Increasing focus on pharmacovigilance and safety surveillance outsourcing to meet evolving global regulatory requirements for post-marketing data collection
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Medical Affairs Outsourcing Market, by Delivery Mode
8.1. Introduction
8.2. Hybrid
8.3. Offsite
8.4. Onsite
9. Medical Affairs Outsourcing Market, by Service Type
9.1. Introduction
9.2. Medical Audit Compliance
9.3. Medical Communications
9.3.1. Medical Education
9.3.2. Scientific Publications
9.3.3. Training
9.4. Medical Information
9.5. Medical Strategy
9.6. Medical Writing
9.6.1. Clinical Trial Writing
9.6.2. Manuscript Writing
9.6.3. Regulatory Writing
9.7. Pharmacovigilance
9.7.1. Case Processing
9.7.2. Risk Management
9.7.3. Signal Detection
10. Medical Affairs Outsourcing Market, by End User
10.1. Introduction
10.2. Biotech Companies
10.3. Contract Research Organizations
10.4. Medical Device Companies
10.5. Pharmaceutical Companies
11. Medical Affairs Outsourcing Market, by Therapeutic Area
11.1. Introduction
11.2. Cardiovascular
11.2.1. Arrhythmia
11.2.2. Heart Failure
11.2.3. Hypertension
11.3. Infectious Disease
11.3.1. Hepatitis
11.3.2. HIV AIDS
11.3.3. Respiratory Infection
11.4. Neurology
11.4.1. Alzheimer Disease
11.4.2. Epilepsy
11.4.3. Parkinson Disease
11.5. Oncology
11.5.1. Breast Cancer
11.5.2. Hematological Cancer
11.5.3. Lung Cancer
12. Americas Medical Affairs Outsourcing Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Medical Affairs Outsourcing Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Medical Affairs Outsourcing Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. IQVIA Holdings Inc.
15.3.2. Syneos Health, Inc.
15.3.3. ICON plc
15.3.4. Parexel International Corporation
15.3.5. Medpace Holdings, Inc.
15.3.6. Thermo Fisher Scientific, Inc.
15.3.7. Envision Pharma Group Limited
15.3.8. Real Chemistry LLC
15.3.9. Synergus LLC
15.3.10. TGaS Advisors, Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. MEDICAL AFFAIRS OUTSOURCING MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY DELIVERY MODE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY DELIVERY MODE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2030 (%)
FIGURE 12. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. MEDICAL AFFAIRS OUTSOURCING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. MEDICAL AFFAIRS OUTSOURCING MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. MEDICAL AFFAIRS OUTSOURCING MARKET: RESEARCHAI
FIGURE 24. MEDICAL AFFAIRS OUTSOURCING MARKET: RESEARCHSTATISTICS
FIGURE 25. MEDICAL AFFAIRS OUTSOURCING MARKET: RESEARCHCONTACTS
FIGURE 26. MEDICAL AFFAIRS OUTSOURCING MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. MEDICAL AFFAIRS OUTSOURCING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY HYBRID, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY HYBRID, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OFFSITE, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OFFSITE, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY ONSITE, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY ONSITE, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL AUDIT COMPLIANCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL AUDIT COMPLIANCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL COMMUNICATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL COMMUNICATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL EDUCATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL EDUCATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SCIENTIFIC PUBLICATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SCIENTIFIC PUBLICATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY TRAINING, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY TRAINING, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL COMMUNICATIONS, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL COMMUNICATIONS, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL INFORMATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL INFORMATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL STRATEGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL STRATEGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL WRITING, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL WRITING, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CLINICAL TRIAL WRITING, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CLINICAL TRIAL WRITING, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MANUSCRIPT WRITING, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MANUSCRIPT WRITING, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY REGULATORY WRITING, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY REGULATORY WRITING, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL WRITING, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL WRITING, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY PHARMACOVIGILANCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY PHARMACOVIGILANCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CASE PROCESSING, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CASE PROCESSING, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY RISK MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY RISK MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SIGNAL DETECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SIGNAL DETECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY PHARMACOVIGILANCE, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY PHARMACOVIGILANCE, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY BIOTECH COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY BIOTECH COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY ARRHYTHMIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY ARRHYTHMIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY HEART FAILURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY HEART FAILURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY HYPERTENSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY HYPERTENSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY HEPATITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY HEPATITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY HIV AIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY HIV AIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY RESPIRATORY INFECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY RESPIRATORY INFECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY INFECTIOUS DISEASE, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY NEUROLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY ALZHEIMER DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY ALZHEIMER DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY EPILEPSY, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY EPILEPSY, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY PARKINSON DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY PARKINSON DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY BREAST CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY HEMATOLOGICAL CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY HEMATOLOGICAL CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY LUNG CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL COMMUNICATIONS, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL COMMUNICATIONS, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL WRITING, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL WRITING, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY PHARMACOVIGILANCE, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY PHARMACOVIGILANCE, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY INFECTIOUS DISEASE, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL COMMUNICATIONS, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL COMMUNICATIONS, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL WRITING, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL WRITING, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY PHARMACOVIGILANCE, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY PHARMACOVIGILANCE, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY INFECTIOUS DISEASE, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 155. CANADA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 156. CANADA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 157. CANADA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 158. CANADA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 159. CANADA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL COMMUNICATIONS, 2018-2024 (USD MILLION)
TABLE 160. CANADA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL COMMUNICATIONS, 2025-2030 (USD MILLION)
TABLE 161. CANADA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL WRITING, 2018-2024 (USD MILLION)
TABLE 162. CANADA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL WRITING, 2025-2030 (USD MILLION)
TABLE 163. CANADA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY PHARMACOVIGILANCE, 2018-2024 (USD MILLION)
TABLE 164. CANADA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY PHARMACOVIGILANCE, 2025-2030 (USD MILLION)
TABLE 165. CANADA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 166. CANADA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 167. CANADA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 168. CANADA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 169. CANADA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 170. CANADA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 171. CANADA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2024 (USD MILLION)
TABLE 172. CANADA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY INFECTIOUS DISEASE, 2025-2030 (USD MILLION)
TABLE 173. CANADA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 174. CANADA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 175. CANADA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 176. CANADA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 177. MEXICO MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 178. MEXICO MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 179. MEXICO MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 180. MEXICO MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 181. MEXICO MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL COMMUNICATIONS, 2018-2024 (USD MILLION)
TABLE 182. MEXICO MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL COMMUNICATIONS, 2025-2030 (USD MILLION)
TABLE 183. MEXICO MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL WRITING, 2018-2024 (USD MILLION)
TABLE 184. MEXICO MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL WRITING, 2025-2030 (USD MILLION)
TABLE 185. MEXICO MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY PHARMACOVIGILANCE, 2018-2024 (USD MILLION)
TABLE 186. MEXICO MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY PHARMACOVIGILANCE, 2025-2030 (USD MILLION)
TABLE 187. MEXICO MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 188. MEXICO MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 189. MEXICO MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 190. MEXICO MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 191. MEXICO MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 192. MEXICO MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 193. MEXICO MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2024 (USD MILLION)
TABLE 194. MEXICO MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY INFECTIOUS DISEASE, 2025-2030 (USD MILLION)
TABLE 195. MEXICO MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 196. MEXICO MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 197. MEXICO MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 198. MEXICO MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 199. BRAZIL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 200. BRAZIL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 201. BRAZIL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 202. BRAZIL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 203. BRAZIL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL COMMUNICATIONS, 2018-2024 (USD MILLION)
TABLE 204. BRAZIL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL COMMUNICATIONS, 2025-2030 (USD MILLION)
TABLE 205. BRAZIL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL WRITING, 2018-2024 (USD MILLION)
TABLE 206. BRAZIL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL WRITING, 2025-2030 (USD MILLION)
TABLE 207. BRAZIL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY PHARMACOVIGILANCE, 2018-2024 (USD MILLION)
TABLE 208. BRAZIL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY PHARMACOVIGILANCE, 2025-2030 (USD MILLION)
TABLE 209. BRAZIL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 210. BRAZIL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 211. BRAZIL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 212. BRAZIL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 213. BRAZIL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 214. BRAZIL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 215. BRAZIL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2024 (USD MILLION)
TABLE 216. BRAZIL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY INFECTIOUS DISEASE, 2025-2030 (USD MILLION)
TABLE 217. BRAZIL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 218. BRAZIL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 219. BRAZIL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 220. BRAZIL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 221. ARGENTINA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 222. ARGENTINA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 223. ARGENTINA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 224. ARGENTINA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 225. ARGENTINA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL COMMUNICATIONS, 2018-2024 (USD MILLION)
TABLE 226. ARGENTINA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL COMMUNICATIONS, 2025-2030 (USD MILLION)
TABLE 227. ARGENTINA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL WRITING, 2018-2024 (USD MILLION)
TABLE 228. ARGENTINA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL WRITING, 2025-2030 (USD MILLION)
TABLE 229. ARGENTINA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY PHARMACOVIGILANCE, 2018-2024 (USD MILLION)
TABLE 230. ARGENTINA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY PHARMACOVIGILANCE, 2025-2030 (USD MILLION)
TABLE 231. ARGENTINA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 232. ARGENTINA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 233. ARGENTINA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 234. ARGENTINA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 235. ARGENTINA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 236. ARGENTINA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 237. ARGENTINA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2024 (USD MILLION)
TABLE 238. ARGENTINA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY INFECTIOUS DISEASE, 2025-2030 (USD MILLION)
TABLE 239. ARGENTINA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 240. ARGENTINA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 241. ARGENTINA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 242. ARGENTINA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL COMMUNICATIONS, 2018-2024 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL COMMUNICATIONS, 2025-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL WRITING, 2018-2024 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL WRITING, 2025-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY PHARMACOVIGILANCE, 2018-2024 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY PHARMACOVIGILANCE, 2025-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2024 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY INFECTIOUS DISEASE, 2025-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 264. EUROPE, MIDDLE EAST & AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 265. EUROPE, MIDDLE EAST & AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 266. EUROPE, MIDDLE EAST & AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 267. UNITED KINGDOM MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 268. UNITED KINGDOM MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 269. UNITED KINGDOM MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 270. UNITED KINGDOM MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 271. UNITED KINGDOM MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL COMMUNICATIONS, 2018-2024 (USD MILLION)
TABLE 272. UNITED KINGDOM MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL COMMUNICATIONS, 2025-2030 (USD MILLION)
TABLE 273. UNITED KINGDOM MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL WRITING, 2018-2024 (USD MILLION)
TABLE 274. UNITED KINGDOM MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL WRITING, 2025-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY PHARMACOVIGILANCE, 2018-2024 (USD MILLION)
TABLE 276. UNITED KINGDOM MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY PHARMACOVIGILANCE, 2025-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 278. UNITED KINGDOM MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 280. UNITED KINGDOM MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 282. UNITED KINGDOM MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 283. UNITED KINGDOM MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2024 (USD MILLION)
TABLE 284. UNITED KINGDOM MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY INFECTIOUS DISEASE, 2025-2030 (USD MILLION)
TABLE 285. UNITED KINGDOM MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY NEUROLOGY, 2018-2024 (USD MILLION)
TABLE 286. UNITED KINGDOM MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY NEUROLOGY, 2025-2030 (USD MILLION)
TABLE 287. UNITED KINGDOM MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 288. UNITED KINGDOM MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 289. GERMANY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 290. GERMANY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 291. GERMANY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 292. GERMANY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 293. GERMANY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL COMMUNICATIONS, 2018-2024 (USD MILLION)
TABLE 294. GERMANY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL COMMUNICATIONS, 2025-2030 (USD MILLION)
TABLE 295. GERMANY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL WRITING, 2018-2024 (USD MILLION)
TABLE 296. GERMANY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL WRITING, 2025-2030 (USD MILLION)
TABLE 297. GERMANY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY PHARMACOVIGILANCE, 2018-2024 (USD MILLION)
TABLE 298. GERMANY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY PHARMACOVIGILANCE, 2025-2030 (USD MILLION)
TABLE 299. GERMANY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 300. GERMANY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 301. GERMANY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 302. GERMANY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 303. GERMANY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 304. GERMANY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 305. GERMANY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2024 (USD MILLION)
TABLE 306. GERMANY MEDICA

Samples

Loading
LOADING...

Companies Mentioned

  • IQVIA Holdings Inc.
  • Syneos Health, Inc.
  • ICON plc
  • Parexel International Corporation
  • Medpace Holdings, Inc.
  • Thermo Fisher Scientific, Inc.
  • Envision Pharma Group Limited
  • Real Chemistry LLC
  • Synergus LLC
  • TGaS Advisors, Inc.

Table Information

Report AttributeDetails
No. of Pages199
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 12.84 Billion
Forecasted Market Value ( USD ) by 2030 $ 25.43 Billion
Compound Annual Growth Rate14.7%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Medical Affairs Outsourcing Market Report 2025 - Product Image

Medical Affairs Outsourcing Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Cancer Immunotherapy Drug Discovery Outsourcing Market by Service Type, Therapeutic Modality, Workflow Stage, End User - Global Forecast 2025-2030 - Product Image

Cancer Immunotherapy Drug Discovery Outsourcing Market by Service Type, Therapeutic Modality, Workflow Stage, End User - Global Forecast 2025-2030

  • Report
  • 187 Pages
  • Global
From
Pharmaceutical Regulatory Affairs - Global Strategic Business Report - Product Image

Pharmaceutical Regulatory Affairs - Global Strategic Business Report

  • Report
  • 478 Pages
  • Global
From
Contract Research Outsourcing - Global Strategic Business Report - Product Image

Contract Research Outsourcing - Global Strategic Business Report

  • Report
  • 453 Pages
  • Global
From
Pharmaceutical CRO Market Size, Share & Trends Analysis Report by Type (Drug Discovery, Pre-Clinical, Clinical), Molecule Type (Small Molecules, Large Molecules), Service, Therapeutic Areas, Region, and Segment Forecasts, 2025-2030 - Product Image

Pharmaceutical CRO Market Size, Share & Trends Analysis Report by Type (Drug Discovery, Pre-Clinical, Clinical), Molecule Type (Small Molecules, Large Molecules), Service, Therapeutic Areas, Region, and Segment Forecasts, 2025-2030

  • Report
  • 231 Pages
  • Global
From

About the Medical Affairs Outsourcing Market

Medical Affairs Outsourcing is a growing segment of the healthcare services industry. It involves the outsourcing of medical affairs activities such as clinical trial management, medical writing, regulatory affairs, and pharmacovigilance. This allows pharmaceutical and biotechnology companies to focus on their core competencies while leveraging the expertise of specialized service providers. Medical Affairs Outsourcing is a cost-effective way to access the latest technology and expertise, while also providing access to a global network of medical professionals. It also helps to reduce the time and cost associated with the development of new drugs and medical devices. Companies in the Medical Affairs Outsourcing market include Parexel, ICON, Syneos Health, PRA Health Sciences, and QuintilesIMS. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.